CN107118161B - The synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid - Google Patents
The synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid Download PDFInfo
- Publication number
- CN107118161B CN107118161B CN201710313540.9A CN201710313540A CN107118161B CN 107118161 B CN107118161 B CN 107118161B CN 201710313540 A CN201710313540 A CN 201710313540A CN 107118161 B CN107118161 B CN 107118161B
- Authority
- CN
- China
- Prior art keywords
- acid
- reaction
- intermediate product
- propyl
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- XWAJTVCEILFDGU-UHFFFAOYSA-N 7-methyl-2-propyl-3h-benzimidazole-5-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2NC(CCC)=NC2=C1C XWAJTVCEILFDGU-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 238000010189 synthetic method Methods 0.000 title claims description 11
- 239000013067 intermediate product Substances 0.000 claims abstract description 41
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 36
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- QDBBTPRTLXPTKN-UHFFFAOYSA-N 4,6-dimethyl-2-propyl-1h-benzimidazole Chemical compound C1=C(C)C=C2NC(CCC)=NC2=C1C QDBBTPRTLXPTKN-UHFFFAOYSA-N 0.000 claims abstract description 19
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 19
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims abstract description 18
- SQHQCZUODQEUMT-UHFFFAOYSA-N 1,5-dimethyl-2,3-dinitrobenzene Chemical compound CC1=CC(C)=C([N+]([O-])=O)C([N+]([O-])=O)=C1 SQHQCZUODQEUMT-UHFFFAOYSA-N 0.000 claims abstract description 15
- DMEPVFSJYHJGCD-UHFFFAOYSA-N 3,5-dimethylbenzene-1,2-diamine Chemical compound CC1=CC(C)=C(N)C(N)=C1 DMEPVFSJYHJGCD-UHFFFAOYSA-N 0.000 claims abstract description 15
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims abstract description 15
- BYFNZOKBMZKTSC-UHFFFAOYSA-N 1,3-dimethyl-5-nitrobenzene Chemical compound CC1=CC(C)=CC([N+]([O-])=O)=C1 BYFNZOKBMZKTSC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920000137 polyphosphoric acid Polymers 0.000 claims abstract description 10
- 239000000047 product Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 229910017604 nitric acid Inorganic materials 0.000 claims abstract description 6
- 239000007791 liquid phase Substances 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 16
- 239000003054 catalyst Substances 0.000 claims description 15
- 229960000583 acetic acid Drugs 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012043 crude product Substances 0.000 claims description 10
- 230000007062 hydrolysis Effects 0.000 claims description 9
- 238000006460 hydrolysis reaction Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000012362 glacial acetic acid Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000005984 hydrogenation reaction Methods 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- AAZSASWTJCLJGM-UHFFFAOYSA-N cobalt;2-ethylhexanoic acid Chemical compound [Co].CCCCC(CC)C(O)=O AAZSASWTJCLJGM-UHFFFAOYSA-N 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 claims description 3
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910017052 cobalt Inorganic materials 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000005457 ice water Substances 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 239000012065 filter cake Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- -1 2-n-propyl Chemical group 0.000 claims 4
- 238000001816 cooling Methods 0.000 claims 2
- 102000011759 adducin Human genes 0.000 claims 1
- 108010076723 adducin Proteins 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 150000001868 cobalt Chemical class 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- 239000005537 C09CA07 - Telmisartan Substances 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 229960005187 telmisartan Drugs 0.000 description 6
- 239000007858 starting material Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 238000006396 nitration reaction Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 230000010933 acylation Effects 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FCMRHMPITHLLLA-UHFFFAOYSA-N 2-methyl-6-nitroaniline Chemical compound CC1=CC=CC([N+]([O-])=O)=C1N FCMRHMPITHLLLA-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- XDTTUTIFWDAMIX-UHFFFAOYSA-N 3-methyl-4-nitrobenzoic acid Chemical compound CC1=CC(C(O)=O)=CC=C1[N+]([O-])=O XDTTUTIFWDAMIX-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000006713 insertion reaction Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- ZHIPSMIKSRYZFV-UHFFFAOYSA-N methyl 4-amino-3-methylbenzoate Chemical compound COC(=O)C1=CC=C(N)C(C)=C1 ZHIPSMIKSRYZFV-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical group C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000000276 potassium ferrocyanide Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
本发明涉及一种2‑正丙基‑4‑甲基苯并咪唑‑6‑羧酸的合成方法。3,5‑二甲基硝基苯经硝酸/浓硫酸硝化反应,生成中间产物Ⅱ 3,5‑二甲基‑1,2‑二硝基苯;中间产物Ⅱ在乙醇溶液中,Pd/C催化氢化反应,得中间产物Ⅲ 3,5‑二甲基‑1,2‑苯二胺;中间产物Ⅲ在多聚磷酸溶液中,与正丁酸反应,得到中间产物Ⅳ 2‑正丙基‑4,6‑二甲基苯并咪唑;中间产物Ⅳ在醋酸溶液中,经钴盐空气液相氧化反应,得产物V 2‑正丙基‑4‑甲基苯并咪唑‑6‑羧酸。本发明操作简单,原料易得,所用溶剂均能回收套用,产品含量可达95%以上,收率高达73.2%,污染少,适合于工业化生产。The invention relates to a method for synthesizing 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid. 3,5-Dimethylnitrobenzene is nitrated by nitric acid/concentrated sulfuric acid to generate intermediate product II 3,5-dimethyl-1,2-dinitrobenzene; intermediate product II is in ethanol solution, Pd/C Catalytic hydrogenation reaction to obtain intermediate product III 3,5-dimethyl-1,2-phenylenediamine; intermediate product III reacts with n-butyric acid in polyphosphoric acid solution to obtain intermediate product IV 2-n-propyl- 4,6-dimethylbenzimidazole; the intermediate product IV is oxidized in the air liquid phase of cobalt salt in acetic acid solution to obtain the product V 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid. The invention has simple operation, easy-to-obtain raw materials, all solvents used can be recovered and used mechanically, the product content can reach more than 95%, the yield is as high as 73.2%, the pollution is less, and it is suitable for industrialized production.
Description
技术领域technical field
本发明属化学制药技术领域,具体涉及一种替米沙坦中间体2-正丙基-4-甲基苯并咪唑-6-羧酸的合成方法。The invention belongs to the technical field of chemical pharmacy, and in particular relates to a synthesis method of telmisartan intermediate 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid.
背景技术Background technique
替米沙坦(telmisartan),作为一类新型血管紧张素Ⅱ受体拮抗剂降压药,其独特的新型双苯并咪唑结构,保证了高度受体亲合力及优越的药代动力学特性,同时又具有先进的作用机理,平稳降压,不反弹,长效高效,耐受性好,靶向选择,副作用小,适应性好等诸多优势,临床用于原发性高血压的治疗,对高血压患者具有良好疗效。Telmisartan (telmisartan), as a new type of angiotensin Ⅱ receptor antagonist antihypertensive drug, its unique new bisbenzimidazole structure ensures high receptor affinity and superior pharmacokinetic properties, At the same time, it has many advantages such as advanced mechanism of action, stable blood pressure reduction, no rebound, long-acting and high-efficiency, good tolerance, targeted selection, small side effects, good adaptability, etc. Hypertensive patients have good curative effect.
二十几年来,国内外学者在替米沙坦的生产工艺和技术上做了大量的研究,提出了许多新工艺和新技术,主要是以甲苯衍生物和苯并咪唑衍生物为原料的两类合成路线。Over the past 20 years, domestic and foreign scholars have done a lot of research on the production process and technology of telmisartan, and proposed many new processes and technologies, mainly using toluene derivatives and benzimidazole derivatives as raw materials. class of synthetic routes.
2-正丙基-4-甲基苯并咪唑-6-羧酸是合成替米沙坦的一个重要中间体。1993年RIES等(Med.Chem.,1993,36(25):4040-4051)以3-甲基-4-氨基苯甲酸甲酯为起始原料,与正丁酰氯在氯苯下进行酰化反应,然后用发烟硝酸和浓硫酸的混酸进行硝化反应,硝化产物在钯/炭催化下进行氢化得到3-甲基-4-正丁酰胺基-5-氨基苯甲酸甲酯。再在冰醋酸的作用下回流环合形成核心苯并咪唑,经氢氧化钠水解,得到2-正丙基-4-甲基苯并咪唑-6-羧酸。2-n-propyl-4-methylbenzimidazole-6-carboxylic acid is an important intermediate in the synthesis of telmisartan. In 1993, RIES et al. (Med.Chem., 1993, 36(25):4040-4051) took 3-methyl-4-aminobenzoic acid methyl ester as the starting material, and carried out acylation with n-butyryl chloride under chlorobenzene reaction, and then carry out nitration reaction with the mixed acid of fuming nitric acid and concentrated sulfuric acid, and the nitration product is hydrogenated under palladium/charcoal catalysis to obtain 3-methyl-4-n-butyramide-5-aminobenzoic acid methyl ester. Then reflux under the action of glacial acetic acid to form the core benzimidazole, which is hydrolyzed by sodium hydroxide to obtain 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid.
湖北省化学研究院曹威等人(甘肃石油和化工,2010,(2):18-22)对2-正丙基-4-甲基-6-羧基苯并咪唑的合成工艺进行了优化研究,确定以3-甲基-4-正丁酰氨基-5-硝基苯甲酸甲酯为原料,经过还原、环合、水解3步反应制得目标产物,总收率为76.3%。Cao Wei, Hubei Institute of Chemistry and others (Gansu Petroleum and Chemical Industry, 2010, (2): 18-22) optimized the synthesis process of 2-n-propyl-4-methyl-6-carboxybenzimidazole , it was determined that the target product was obtained through 3-step reaction of reduction, cyclization and hydrolysis with 3-methyl-4-n-butyrylamino-5-nitrobenzoic acid methyl ester as raw material, and the total yield was 76.3%.
CN101983962A,一种替米沙坦原料药的制备工艺,其中公开的内容有:以3-甲基-4-硝基-苯甲酸为起始原料,经酯化、还原得到4-氨基-3-甲基苯甲酸甲酯,经酰化、发烟硝酸硝化、还原、环合、水解得到2-正丙基-4-甲基苯并咪唑-6-羧酸。CN101983962A, a preparation process of telmisartan bulk drug, wherein the disclosed content includes: 3-methyl-4-nitro-benzoic acid is used as the starting material, and 4-amino-3-benzoic acid is obtained through esterification and reduction Methyl benzoate, after acylation, nitration with fuming nitric acid, reduction, cyclization, hydrolysis to obtain 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid.
2010年HanseImami申请的专利(WO,2010149360)报道了以廉价的邻甲基苯胺为起始原料,通过正丁酰氯酰基化、Br/H2O2体系溴化、钯催化引入氰基、混酸硝化、铁粉-冰醋酸体系还原关环、浓盐酸水解共6步反应合成2-正丙基-4-甲基苯并咪唑-6-羧酸,总收率为4%。该路线起始原料邻甲基苯胺价格便宜、路线较短,缺点是导入氰基需要使用到亚铁氰化钾剧毒品,且溶剂DMF回收困难,后处理繁琐;硫酸和浓盐酸等腐蚀性化学品,可操作性较差,污染严重。该工艺不适合工业化生产。The patent (WO, 2010149360) applied by HanseImami in 2010 reported the use of cheap o-methylaniline as a starting material, through acylation of n-butyryl chloride, bromination of Br/H 2 O 2 system, palladium catalyzed introduction of cyano groups, and mixed acid nitration 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid was synthesized in 6 steps including reduction ring closure with iron powder-glacial acetic acid system and hydrolysis with concentrated hydrochloric acid, with a total yield of 4%. The starting material o-methylaniline of this route is cheap and the route is short. The disadvantage is that the introduction of cyano groups requires the use of potassium ferrocyanide, a highly toxic substance, and the recovery of the solvent DMF is difficult, and the post-treatment is cumbersome; corrosive substances such as sulfuric acid and concentrated hydrochloric acid Chemicals, poor operability and serious pollution. This process is not suitable for industrial production.
Buechime申请的专利(WO,201081670)报道了以2-甲基-6-硝基苯胺为原料,通过HBr/H2O2溴化、Na2S2O4还原关环、把催化引入羰基和氢氧化钠水解共4步反应合成2-正丙基-4-甲基苯并咪唑-6-羧酸。4步反应收率高达54%。但是用保险粉做还原剂需要量大。另外,由于Na2S2O4遇水易分解放出SO2气体污染环境,因此其工业应用受到限制。The patent (WO, 201081670) applied by Buechime reported that 2-methyl-6-nitroaniline was used as raw material, through HBr/H 2 O 2 bromination, Na 2 S 2 O 4 reduction ring closure, introduction of catalysis into carbonyl and 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid was synthesized by sodium hydroxide hydrolysis in four steps. The 4-step reaction yield is as high as 54%. But using hydrosulfite as reducing agent requires a large amount. In addition, because Na 2 S 2 O 4 easily decomposes with water and releases SO 2 gas to pollute the environment, so its industrial application is limited.
复旦大学马学成(复旦大学硕士论文,2012)以廉价易得的2-甲基-6-硝基苯胺为原料,经NBS溴化、正丁酰氯在100℃下酰化、铁粉/氯化铵在乙醇和水中还原、醋酸介质中加热环合、Pd(dppf)Cl2催化100℃下插入羰基、氢氧化钠水解共6步得到2-正丙基-4-甲基苯并咪唑-6-羧酸,总收率达62%。此路线具有收率高,成本低,污染小,工艺反应条件温和,操作简单实用,具有较好的工业化应用前景。但催化插羰反应需要温度100℃,一氧化碳压力1.5MPa的高压和重金属钯催化。Ma Xuecheng of Fudan University (Master's thesis of Fudan University, 2012) used cheap and easy-to-obtain 2-methyl-6-nitroaniline as raw material, brominated with NBS, acylated with n-butyryl chloride at 100°C, iron powder/ammonium chloride Reduction in ethanol and water, heating and cyclization in acetic acid medium, Pd(dppf)Cl 2 catalyzed insertion of carbonyl at 100°C, and hydrolysis with sodium hydroxide are a total of 6 steps to obtain 2-n-propyl-4-methylbenzimidazole-6- Carboxylic acid, the total yield reaches 62%. This route has the advantages of high yield, low cost, little pollution, mild process reaction conditions, simple and practical operation, and has good industrial application prospect. However, the catalytic carbonyl insertion reaction requires a high temperature of 100°C, a carbon monoxide pressure of 1.5MPa, and a heavy metal palladium catalyst.
发明内容Contents of the invention
本发明的目的是针对上述技术现状,旨在提供一种产品收率和纯度高,环境污染小、成本低,具有巨大的经济效益和社会效益的2-正丙基-4-甲基苯并咪唑-6-羧酸的合成方法。The purpose of the present invention is aimed at above-mentioned technical present situation, aims to provide a kind of product yield and purity high, environmental pollution is little, cost is low, has huge economic benefit and social benefit 2-n-propyl-4-methylbenzo Synthetic method of imidazole-6-carboxylic acid.
本发明目的的实现方式为,2-正丙基-4-甲基苯并咪唑-6-羧酸的合成方法,合成方法分四步进行:The realization mode of the object of the present invention is, the synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid, and synthetic method is carried out in four steps:
第一步,以3,5-二甲基硝基苯为原料,经硝酸/浓硫酸硝化反应,水解,过滤,生成中间产物Ⅱ3,5-二甲基-1,2-二硝基苯;In the first step, 3,5-dimethylnitrobenzene is used as raw material, nitrated by nitric acid/concentrated sulfuric acid, hydrolyzed, and filtered to generate intermediate product II 3,5-dimethyl-1,2-dinitrobenzene;
第二步,将第一步所得的中间产物3,5-二甲基-1,2-二硝基苯溶解在乙醇中,Pd/C催化氢化反应,实现硝基变成氨基的反应,经过滤、浓缩,得中间产物Ⅲ3,5-二甲基-1,2-苯二胺;In the second step, the intermediate product 3,5-dimethyl-1,2-dinitrobenzene obtained in the first step is dissolved in ethanol, and Pd/C catalyzes the hydrogenation reaction to realize the reaction of nitro group into amino group. Filtration and concentration yielded the intermediate product III 3,5-dimethyl-1,2-phenylenediamine;
第三步,将第二步所得的中间产物3,5-二甲基-1,2-苯二胺在多聚磷酸溶液,与正丁酸反应,经活性炭脱色,过滤,氢氧化钠中和至pH8,得到中间产物Ⅳ2-正丙基-4,6-二甲基苯并咪唑;In the third step, the intermediate product 3,5-dimethyl-1,2-phenylenediamine obtained in the second step is reacted with n-butyric acid in polyphosphoric acid solution, decolorized by activated carbon, filtered, and neutralized by sodium hydroxide To pH8, the intermediate product IV 2-n-propyl-4,6-dimethylbenzimidazole was obtained;
第四步,将第三步所得的中间产物2-正丙基-4,6-二甲基苯并咪唑在醋酸溶液中,经钴盐空气液相氧化反应,实现6位甲基变成羧基的反应,经浓缩,碱解,过滤,酸解,得到产品V 2-正丙基-4-甲基苯并咪唑-6-羧酸;In the fourth step, the intermediate product 2-n-propyl-4,6-dimethylbenzimidazole obtained in the third step is subjected to an air-liquid phase oxidation reaction of cobalt salt in an acetic acid solution to realize the conversion of the methyl group at the 6-position into a carboxyl group The reaction is concentrated, alkali hydrolyzed, filtered, and acidolyzed to obtain product V 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid;
具体反应通过下式进行:Concrete reaction carries out by following formula:
本发明以3,5-二甲基硝基苯为起始原料,经浓硝酸/浓硫酸硝化,钯/碳催化加氢,多聚磷酸环合,钴催化下的空气氧化,得到2-正丙基-4-甲基苯并咪唑-6-羧酸,操作简单,原料易得,所用溶剂均能回收套用,收率高达73.2%,污染少,本发明适合于工业化生产。The present invention uses 3,5-dimethylnitrobenzene as the starting material, nitrates with concentrated nitric acid/concentrated sulfuric acid, catalyzes hydrogenation with palladium/carbon, cyclizes polyphosphoric acid, and oxidizes air under the catalysis of cobalt to obtain 2-normal Propyl-4-methylbenzimidazole-6-carboxylic acid has simple operation, readily available raw materials, all solvents used can be recovered and used mechanically, the yield is as high as 73.2%, and there is less pollution. The invention is suitable for industrial production.
具体实施方式Detailed ways
本发明合成方法分四步进行:The synthetic method of the present invention is carried out in four steps:
第一步,以3,5-二甲基硝基苯为原料,经硝酸/浓硫酸硝化反应,水解,过滤,生成中间产物Ⅱ3,5-二甲基-1,2-二硝基苯。In the first step, 3,5-dimethylnitrobenzene is used as raw material, nitrated by nitric acid/concentrated sulfuric acid, hydrolyzed, and filtered to generate intermediate product II 3,5-dimethyl-1,2-dinitrobenzene.
具体为:将95%发烟硝酸和98%的浓硫酸配制成混合酸,0℃下保存;在反应容器中加入98%的浓硫酸和3,5-二甲基硝基苯,搅拌下冷却至-10℃,滴加95%的发烟硝酸和98%的浓硫酸配制成的混合酸,控制加料速度使反应温度不高于-5℃。滴加完毕后,继续冰浴搅拌3小时,将反应混合物缓慢加至碎冰中水解,维持温度不超过5℃,剧烈搅拌,至大量淡黄色固体析出;过滤,滤饼分别用冰水,饱和碳酸氢钠溶液,清水洗涤,晾干,得中间产物II,淡黄色固体3,5-二甲基-1,2-二硝基苯。Specifically: prepare a mixed acid with 95% fuming nitric acid and 98% concentrated sulfuric acid, and store it at 0°C; add 98% concentrated sulfuric acid and 3,5-dimethylnitrobenzene into the reaction vessel, and cool it under stirring To -10°C, add dropwise the mixed acid prepared by 95% fuming nitric acid and 98% concentrated sulfuric acid, and control the feeding rate so that the reaction temperature is not higher than -5°C. After the dropwise addition, continue to stir in the ice bath for 3 hours, slowly add the reaction mixture to crushed ice for hydrolysis, keep the temperature not exceeding 5°C, and stir vigorously until a large amount of light yellow solid precipitates; filter and filter the cake with ice water, saturated Sodium bicarbonate solution, washed with water, and dried to obtain intermediate product II, 3,5-dimethyl-1,2-dinitrobenzene as light yellow solid.
所述95%的发烟硝酸和98%的浓硫酸配制的混合酸的体积比为1:2,混合酸与3,5-二甲基硝基苯的用量比为3ml:1g。The volume ratio of the mixed acid prepared by the 95% fuming nitric acid and 98% concentrated sulfuric acid is 1:2, and the dosage ratio of the mixed acid to 3,5-dimethylnitrobenzene is 3ml:1g.
第二步,将第一步所得的中间产物3,5-二甲基-1,2-二硝基苯溶解在乙醇中,Pd/C催化氢化反应,实现硝基变成氨基的反应,经过滤、浓缩,得中间产物Ⅲ3,5-二甲基-1,2-苯二胺;In the second step, the intermediate product 3,5-dimethyl-1,2-dinitrobenzene obtained in the first step is dissolved in ethanol, and Pd/C catalyzes the hydrogenation reaction to realize the reaction of nitro group into amino group. Filtration and concentration yielded the intermediate product III 3,5-dimethyl-1,2-phenylenediamine;
具体为:向高压反应釜中加入第一步所得的中间产物3,5-二甲基-1,2-二硝基苯,然后加入5%Pd/C催化剂,甲醇溶剂,在温度60℃、压力0.5Mpa进行6h加氢反应,反应结束后,降温降压开釜,过滤回收催化剂,除去溶剂,结晶,得到中间产物III 3,5-二甲基-1,2-苯二胺;Specifically: add the intermediate product 3,5-dimethyl-1,2-dinitrobenzene obtained in the first step into the autoclave, then add 5% Pd/C catalyst, methanol solvent, The hydrogenation reaction was carried out at a pressure of 0.5Mpa for 6 hours. After the reaction was completed, the temperature and pressure were lowered to open the kettle, the catalyst was recovered by filtration, the solvent was removed, and crystallized to obtain the intermediate product III 3,5-dimethyl-1,2-phenylenediamine;
所述催化剂为5%Pd/C与中间产物3,5-二甲基-1,2-二硝基苯的用量比为1g:10g。The catalyst is 5% Pd/C and the amount ratio of intermediate product 3,5-dimethyl-1,2-dinitrobenzene is 1g:10g.
第三步,将第二步所得的中间产物3,5-二甲基-1,2-苯二胺在多聚磷酸溶液,与正丁酸反应,经活性炭脱色,过滤,氢氧化钠中和至pH8,得到中间产物Ⅳ 2-正丙基-4,6-二甲基苯并咪唑;In the third step, the intermediate product 3,5-dimethyl-1,2-phenylenediamine obtained in the second step is reacted with n-butyric acid in polyphosphoric acid solution, decolorized by activated carbon, filtered, and neutralized by sodium hydroxide To pH8, the intermediate product IV 2-n-propyl-4,6-dimethylbenzimidazole was obtained;
具体为:在反应容器中加入第二步制备中间的产物3,5-二甲基-1,2-苯二胺,加入丁酸,多聚磷酸到反应瓶中。升温到120-125℃,反应16小时;降温到60℃,再加水,活性炭,搅拌溶解至微沸,约30min后趁热过滤。冷却滤液,在搅拌条件下向反应液中加入氢氧化钠溶液中和至pH 10;冷却抽滤,将析出的固体滤出,用冷水洗涤、干燥得粗品;粗品用乙醇重结晶,析出晶体后抽滤,100℃下烘干,得中间体IV 2-正丙基-4,6-二甲基苯并咪唑。Specifically: add 3,5-dimethyl-1,2-phenylenediamine, an intermediate product prepared in the second step, into the reaction vessel, and add butyric acid and polyphosphoric acid into the reaction vessel. Raise the temperature to 120-125°C and react for 16 hours; cool down to 60°C, add water and activated carbon, stir and dissolve until slightly boiling, filter while hot after about 30 minutes. Cool the filtrate, add sodium hydroxide solution to the reaction solution under stirring conditions to neutralize to pH 10; cool and suction filter, filter out the precipitated solid, wash with cold water, and dry to obtain the crude product; the crude product is recrystallized with ethanol, and after the crystals are precipitated Suction filtration and drying at 100°C gave intermediate IV 2-n-propyl-4,6-dimethylbenzimidazole.
中间的产物3,5-二甲基-1,2-苯二胺与丁酸的用量比为8g:9g,与多聚磷酸的用量比为40g:80g,与活性炭的用量比为20g:1g,与乙醇的用量比为4g:50ml。The amount ratio of the intermediate product 3,5-dimethyl-1,2-phenylenediamine to butyric acid is 8g:9g, the amount ratio to polyphosphoric acid is 40g:80g, and the amount ratio to activated carbon is 20g:1g , and the amount ratio of ethanol is 4g:50ml.
第四步,将第三步所得的中间产物2-正丙基-4,6-二甲基苯并咪唑在醋酸溶液中,经钴盐空气液相氧化反应,实现6位甲基变成羧基的反应,经浓缩,碱解,过滤,酸解,得到产品V 2-正丙基-4-甲基苯并咪唑-6-羧酸。In the fourth step, the intermediate product 2-n-propyl-4,6-dimethylbenzimidazole obtained in the third step is subjected to an air-liquid phase oxidation reaction of cobalt salt in an acetic acid solution to realize the conversion of the methyl group at the 6-position into a carboxyl group The reaction was concentrated, alkali hydrolyzed, filtered, and acidolyzed to obtain the product V 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid.
具体为,在反应容器中加入第三步所得的中间产物IV 2-正丙基-4,6-二甲基苯并咪唑,加入催化剂2-乙基己酸钴,助催化剂N-羟基邻苯二甲酰亚胺,冰醋酸;在温度为110℃,氧气压力1MPa,反应2h;反应停止后,降温降压开釜,减压脱出乙酸,得到沉淀,抽滤,得粗品,粗品用10%氢氧化钠水溶液中和到pH=8-9,加活性炭除色,过滤,滤液经6N酸化至pH=3,过滤,烘干,得到类白色结晶性固体2-正丙基-4-甲基苯并咪唑-6-羧酸(V);Specifically, the intermediate product IV 2-n-propyl-4,6-dimethylbenzimidazole obtained in the third step is added to the reaction vessel, the catalyst 2-ethylhexanoic acid cobalt, and the cocatalyst N-hydroxy-phthalic acid Dicarboximide, glacial acetic acid; at a temperature of 110°C and an oxygen pressure of 1 MPa, react for 2 hours; after the reaction stops, lower the temperature and pressure to open the kettle, depressurize to remove acetic acid, obtain a precipitate, and filter with suction to obtain a crude product, which is used in 10% Sodium hydroxide aqueous solution is neutralized to pH = 8-9, add activated carbon to remove color, filter, the filtrate is acidified with 6N to pH = 3, filter, dry to obtain off-white crystalline solid 2-n-propyl-4-methyl Benzimidazole-6-carboxylic acid (V);
所述催化剂2-乙基己酸钴、助催化剂N-羟基邻苯二甲酰亚胺与2-正丙基-4,6-二甲基苯并咪唑的用量比为0.5g:20g;The dosage ratio of the catalyst 2-cobalt ethylhexanoate, cocatalyst N-hydroxyphthalimide and 2-n-propyl-4,6-dimethylbenzimidazole is 0.5g: 20g;
冰醋酸与2-正丙基-4,6-二甲基苯并咪唑的用量比为15ml:20g。The dosage ratio of glacial acetic acid to 2-n-propyl-4,6-dimethylbenzimidazole is 15ml:20g.
下面用具体实施例对本发明作进一步描述The present invention will be further described below with specific embodiment
第一步、合成3,5-二甲基-1,2-二硝基苯The first step, synthesis of 3,5-dimethyl-1,2-dinitrobenzene
将95%的发烟硝酸20mL和98%的浓硫酸40mL配制成混合酸,搅拌下冷却至-10℃保存。向装有机械搅拌的500ml三口烧瓶中加入100ml浓硫酸,20g 3,5-二甲基硝基苯。搅拌下用低温槽冷却至-10℃,分批滴加发烟硝酸和98%的浓硫酸的混合酸,控制加料速度,使反应温度不高于-5℃。加料完毕后,继续冰浴搅拌3小时。将待反应混合物颜色变深后,将反应液缓慢加至碎冰中水解,维持温度不超过5℃,剧烈搅拌,可见大量淡黄色固体析出。过滤,滤饼分别用冰水,饱和碳酸氢钠溶液,清水洗涤,晾干,得21g中间产物II,淡黄色固体3,5-二甲基-1,2-二硝基苯,收率92.8%,熔点132.7-134.7℃。Mix 20mL of 95% fuming nitric acid and 40mL of 98% concentrated sulfuric acid to make a mixed acid, and store it under stirring at -10°C. Add 100ml of concentrated sulfuric acid and 20g of 3,5-dimethylnitrobenzene into a 500ml three-necked flask equipped with mechanical stirring. Cool to -10°C with a low-temperature tank under stirring, add fuming nitric acid and 98% concentrated sulfuric acid mixture dropwise in batches, and control the feeding speed so that the reaction temperature is not higher than -5°C. After the addition was complete, stirring was continued in the ice bath for 3 hours. After the color of the reaction mixture became darker, slowly add the reaction solution into crushed ice for hydrolysis, keep the temperature not exceeding 5°C, stir vigorously, and a large amount of light yellow solid can be seen to precipitate. Filtration, the filter cake was washed with ice water, saturated sodium bicarbonate solution, water, and dried to obtain 21g of intermediate product II, light yellow solid 3,5-dimethyl-1,2-dinitrobenzene, yield 92.8 %, melting point 132.7-134.7°C.
红外光谱IR仪器型号Perkin-Elmer Spectrum(KBr,cm-1):3088(Ar-H);2919(CH3-H);1547,1441(Ar-C);1547,1362(N=O);1441,1362(-CH3);1040(C-N);876-763(Ar-H)。Infrared spectrum IR instrument model Perkin-Elmer Spectrum (KBr, cm -1 ): 3088 (Ar-H); 2919 (CH 3 -H); 1547, 1441 (Ar-C); 1547, 1362 (N=O); 1441, 1362 ( -CH3 ); 1040 (CN); 876-763 (Ar-H).
核磁共振NMR仪器型号Varian Mercury 400,1H-NMR(CDCl3):7.79(S,1H,Ar-H);7.43(S,1H,Ar-H);2.50(S,3H,Ar-CH3);2.40(S,3H,Ar-CH3)。Nuclear magnetic resonance NMR instrument model Varian Mercury 400, 1 H-NMR (CDCl 3 ): 7.79 (S, 1H, Ar-H); 7.43 (S, 1H, Ar-H); 2.50 (S, 3H, Ar-CH 3 ); 2.40 (S,3H,Ar—CH 3 ).
质谱分析仪器Xevo TQ。MS:m/z=196.02(M+);Mass spectrometry instrument Xevo TQ. MS: m/z=196.02 (M + );
第二步、合成3,5-二甲基-1,2-苯二胺The second step, synthesis of 3,5-dimethyl-1,2-phenylenediamine
确定反应釜不漏气后,向高压反应釜中加入15g 3,5-二甲基-1,2-二硝基苯,然后加入1.5g的5%Pd/C催化剂,再向高压容器中加入300ml甲醇。先通入一定压力的氮气,排空反应釜中的空气,连续排三次,再通入一定压力的氢气置换氮气,连续置换三次。最后在60℃、反应压力0.5Mpa和6h下反应。降温降压开釜,用气相色谱检测釜内原料、产物及副产物的含量,过滤回收催化剂,除去溶剂,结晶,得到10.5g中间产物III 3,5-二甲基-1,2-苯二胺,经GC检测纯度大于98%,收率98.8%,熔点73.9-74.6℃。After confirming that the reactor is airtight, add 15g of 3,5-dimethyl-1,2-dinitrobenzene to the autoclave, then add 1.5g of 5% Pd/C catalyst, and then add 300ml methanol. First pass nitrogen at a certain pressure, empty the air in the reactor, and discharge it three times in a row, then pass in hydrogen at a certain pressure to replace the nitrogen, and replace it three times in a row. Finally, the reaction was carried out at 60° C. under a reaction pressure of 0.5 MPa and 6 hours. Lower the temperature and reduce the pressure to open the kettle, use gas chromatography to detect the content of raw materials, products and by-products in the kettle, filter and recover the catalyst, remove the solvent, and crystallize to obtain 10.5g of intermediate product III 3,5-dimethyl-1,2-benzenedi The amine has a purity of more than 98% detected by GC, a yield of 98.8%, and a melting point of 73.9-74.6°C.
红外光谱IR仪器型号Perkin-Elmer Spectrum(KBr,cm-1):3392,3299(Ar-NH2);2916(Ar-CH3);912(Ar-H)。Infrared spectrum IR instrument model Perkin-Elmer Spectrum (KBr, cm -1 ): 3392, 3299 (Ar-NH 2 ); 2916 (Ar-CH 3 ); 912 (Ar-H).
核磁共振NMR仪器型号Varian Mercury 400,1H-NMR(CDCl3):6.23(S,1H,Ar-H);6.12(S,1H,Ar-H);4.11(br,4H,Ar-NH2);2.03(S,3H,Ar-CH3);1.99(S,3H,Ar-CH3)。Nuclear magnetic resonance NMR instrument model Varian Mercury 400, 1 H-NMR (CDCl 3 ): 6.23 (S, 1H, Ar-H); 6.12 (S, 1H, Ar-H); 4.11 (br, 4H, Ar-NH 2 ); 2.03 (S,3H,Ar—CH 3 ); 1.99 (S,3H,Ar—CH 3 ).
质谱分析仪器Xevo TQ。MS:m/z=136.08(M+)。Mass spectrometry instrument Xevo TQ. MS: m/z = 136.08 (M + ).
第三步、合成2-正丙基-4,6-二甲基苯并咪唑The third step, synthesis of 2-n-propyl-4,6-dimethylbenzimidazole
取40g3,5-二甲基-1,2-苯二胺,45g丁酸,80g多聚磷酸加到反应瓶中。升温到120-125℃,反应16小时。降温到60℃,再加水500g,2g活性炭,搅拌溶解至微沸,约30min后趁热过滤。冷却滤液,在搅拌条件下向反应液中加入10%氢氧化钠溶液,中和pH至10左右。冷却抽滤,将析出的固体滤出,用冷水洗涤、干燥得粗品。Take 40g of 3,5-dimethyl-1,2-phenylenediamine, 45g of butyric acid, and 80g of polyphosphoric acid into the reaction flask. Raise the temperature to 120-125°C and react for 16 hours. Cool down to 60°C, add 500g of water and 2g of activated carbon, stir and dissolve until slightly boiling, filter while hot after about 30min. Cool the filtrate, add 10% sodium hydroxide solution to the reaction solution under stirring condition, and neutralize the pH to about 10. Cool and filter with suction, filter out the precipitated solid, wash with cold water, and dry to obtain a crude product.
将粗品置于1000mL烧杯中,加入500mL乙醇,加热溶解。冷至室温,析出晶体后抽滤,最后在100℃下烘干,得51g中间产物IV 2-正丙基-4,6-二甲基苯并咪唑。经HPLC检测纯度大于98%,收率90%,熔点167.7-170.2℃。Put the crude product in a 1000mL beaker, add 500mL ethanol, and heat to dissolve. Cool to room temperature, precipitate crystals, filter with suction, and finally dry at 100°C to obtain 51g of intermediate product IV 2-n-propyl-4,6-dimethylbenzimidazole. The purity detected by HPLC is greater than 98%, the yield is 90%, and the melting point is 167.7-170.2°C.
红外光谱IR仪器型号Perkin-Elmer Spectrum(KBr,cm-1):3249(Ar-CH3);2962(-CH3);2931(-CH2-);1652(C=N)。Infrared spectrum IR instrument model Perkin-Elmer Spectrum (KBr, cm -1 ): 3249 (Ar-CH 3 ); 2962 (-CH 3 ); 2931 (-CH 2 -); 1652 (C=N).
核磁共振NMR仪器型号Varian Mercury 400,1H-NMR(CDCl3):7.99,8.31(S,3H,Ar-CH3);6.74(S,1H,Ar-NH-);2.27(q,2H,-CH2-);2.13,2.16(S,3H,Ar-CH3);1.55(dq,2H,-CH2-);0.9(dt,3H,Ar-CH3)。Nuclear magnetic resonance NMR instrument model Varian Mercury 400, 1 H-NMR (CDCl 3 ): 7.99, 8.31 (S, 3H, Ar-CH 3 ); 6.74 (S, 1H, Ar-NH-); 2.27 (q, 2H, -CH 2 -); 2.13, 2.16 (S, 3H, Ar-CH 3 ); 1.55 (dq, 2H, -CH 2 -); 0.9 (dt, 3H, Ar-CH 3 ).
质谱分析仪器Xevo TQ。MS:m/z=188.19(M+)。Mass spectrometry instrument Xevo TQ. MS: m/z = 188.19 (M + ).
第四步、合成2-正丙基-4-甲基苯并咪唑-6-羧酸The fourth step, synthesis of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid
确定反应釜不漏气后,向高压反应釜中加入20g 2-正丙基-4,6-二甲基苯并咪唑,催化剂2-乙基己酸钴0.5g,助催化剂N-羟基邻苯二甲酰亚胺0.5g,冰醋酸15ml。在温度为110℃,氧气压力在1MPa,反应时间在2h。反应停止后,降温降压开釜,减压脱出乙酸,得到沉淀,将得到的沉淀进行抽滤,粗品用10%氢氧化钠水溶液中和到pH=8-9,加活性炭除色,过滤,滤液经6N酸化至pH=3,过滤得到类白色结晶性固体V 2-正丙基-4-甲基苯并咪唑-6-羧酸。After confirming that the reactor is airtight, add 20g of 2-n-propyl-4,6-dimethylbenzimidazole to the autoclave, 0.5g of cobalt 2-ethylhexanoate as a catalyst, and 0.5g of cocatalyst N-hydroxy-phthalate Dicarboximide 0.5g, glacial acetic acid 15ml. The temperature is 110°C, the oxygen pressure is 1MPa, and the reaction time is 2h. After the reaction stopped, lower the temperature and reduce the pressure to open the kettle, remove the acetic acid under reduced pressure to obtain a precipitate, filter the obtained precipitate with suction, neutralize the crude product with 10% aqueous sodium hydroxide solution to pH = 8-9, add activated carbon to remove color, filter, The filtrate was acidified with 6N to pH=3, and filtered to obtain V 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid as an off-white crystalline solid.
2-正丙基-4,6-二甲基苯并咪唑单程转化率可达40%,2-正丙基-4-甲基苯并咪唑-6-羧酸的选择性达100%。产品经乙醇重结晶,得到20.6g 2-正丙基-4-甲基苯并咪唑-6-羧酸,HPLC检测纯度大于98%,总收率88.8%,熔点257.7-259.3℃。The single-pass conversion rate of 2-n-propyl-4,6-dimethylbenzimidazole can reach 40%, and the selectivity of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid can reach 100%. The product was recrystallized from ethanol to obtain 20.6g of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid, the purity of which was detected by HPLC was greater than 98%, the total yield was 88.8%, and the melting point was 257.7-259.3°C.
红外光谱IR仪器型号Perkin-Elmer Spectrum(KBr,cm-1):3425(O-H);2965(Ar-CH3);1650(C=N)。Infrared spectrum IR instrument model Perkin-Elmer Spectrum (KBr, cm -1 ): 3425 (OH); 2965 (Ar-CH 3 ); 1650 (C=N).
核磁共振NMR仪器型号Varian Mercury 400,1H-NMR(CDCl3):12.59(b,1H,Ar-COOH);7.93(S,1H,Ar-H);7.61(S,1H,Ar-H);3.55(b,1H,Ar-NH-);2.88(t,2H,-CH2-);2.55(S,3H,Ar-CH3);1.81(m,2H,-CH2-);1.02(t,3H,Ar-CH3)。Nuclear magnetic resonance NMR instrument model Varian Mercury 400, 1 H-NMR (CDCl 3 ): 12.59 (b, 1H, Ar-COOH); 7.93 (S, 1H, Ar-H); 7.61 (S, 1H, Ar-H) ; 3.55(b,1H,Ar-NH-); 2.88(t,2H,-CH 2 -); 2.55(S,3H,Ar-CH 3 ); 1.81(m,2H,-CH 2 -); 1.02 (t,3H,Ar—CH 3 ).
质谱分析仪器Xevo TQ。MS:m/z=218.25(M+)。Mass spectrometry instrument Xevo TQ. MS: m/z = 218.25 (M + ).
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710313540.9A CN107118161B (en) | 2017-05-05 | 2017-05-05 | The synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710313540.9A CN107118161B (en) | 2017-05-05 | 2017-05-05 | The synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107118161A CN107118161A (en) | 2017-09-01 |
CN107118161B true CN107118161B (en) | 2019-12-31 |
Family
ID=59727592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710313540.9A Expired - Fee Related CN107118161B (en) | 2017-05-05 | 2017-05-05 | The synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107118161B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111689903A (en) * | 2020-07-17 | 2020-09-22 | 浙江金立源药业有限公司 | Synthesis method of 2-n-propyl-4-methyl-6- (1-methylbenzimidazole-2-yl) benzimidazole |
CN114621096A (en) * | 2020-12-11 | 2022-06-14 | 余购粮 | A kind of synthetic method of 3,5-dimethyl-1,2-phenylenediamine dihydrochloride |
CN114621101A (en) * | 2020-12-11 | 2022-06-14 | 李冰坚 | A kind of purification method of 3,5-dimethyl-1,2-phenylenediamine dihydrochloride |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101263136A (en) * | 2005-07-13 | 2008-09-10 | 弗·哈夫曼-拉罗切有限公司 | Benzimidazole derivatives as 5-HT6, 5-HT24 |
CN103319414A (en) * | 2013-07-01 | 2013-09-25 | 北京理工大学 | Improved telmisartan preparation process |
CN104610161A (en) * | 2015-01-05 | 2015-05-13 | 河南师范大学 | Preparation method for telmisartan |
-
2017
- 2017-05-05 CN CN201710313540.9A patent/CN107118161B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101263136A (en) * | 2005-07-13 | 2008-09-10 | 弗·哈夫曼-拉罗切有限公司 | Benzimidazole derivatives as 5-HT6, 5-HT24 |
CN103319414A (en) * | 2013-07-01 | 2013-09-25 | 北京理工大学 | Improved telmisartan preparation process |
CN104610161A (en) * | 2015-01-05 | 2015-05-13 | 河南师范大学 | Preparation method for telmisartan |
Non-Patent Citations (2)
Title |
---|
Interpenetrating chiral 2D grid nets: hetero- versus homochiral 3D polycatenation in the crystal self-assembly of (RS)- and (R)-1,10-binaphthalene-2,20,6,60-tetracarboxylic acids;Petr Holy,等;《Tetrahedron: Asymmetry》;20051231(第16期);2031-2038 * |
Molecular modeling and synthesis of certain substituted aryl compounds which have a potential anticancer activity;Hosam A. Ahmed;《Bulletin of Faculty of Pharmacy,,Cairo University》;20110826;第49卷;25–36 * |
Also Published As
Publication number | Publication date |
---|---|
CN107118161A (en) | 2017-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107118161B (en) | The synthetic method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid | |
CN108383749B (en) | Synthetic method of apaluamide and intermediate thereof | |
CN103319414A (en) | Improved telmisartan preparation process | |
CN111423382A (en) | Preparation method of telmisartan key intermediate | |
CN115124465B (en) | Preparation method of quinclorac intermediate | |
CN103044491B (en) | Dimethyl carbonate synthesis method by using methanol and carbon dioxide | |
CN102190592A (en) | Synthetic method of methanamide compound | |
CN111620844A (en) | Preparation method of alpha-acetyl-gamma-butyrolactone | |
CN102295577A (en) | Synthetic method of sartanbipheny and derivatives thereof | |
CN102351790A (en) | Method for synthesizing 7-bromo-6-chloro-4-quinazolinone | |
CN110818590A (en) | The preparation method of p-hydroxybenzonitrile | |
CN114369099B (en) | Method for preparing pyromellitic dianhydride by liquid-phase oxidation | |
CN101735152A (en) | 2,2'-(1,4-phenylene)bi(benzimidazole-5-carboxylic acid) and preparation method thereof | |
CN101306386A (en) | Palladium catalyst for the synthesis of oxalate by liquid phase coupling method and its application | |
WO2022061920A1 (en) | Method for preparing 3',5'-dichloro-2,2,2-trifluoroacetophenone | |
CN113968803B (en) | Method for synthesizing 2, 6-difluoro-3-propyl sulfonamide benzoic acid | |
US20220235010A1 (en) | Synthesis method for 1-methyl-1h-indazole-6-carboxylic acid | |
CN101088999A (en) | The synthetic method of 3-aminoquinine dihydrochloride | |
CN101412678B (en) | Method for synthesizing memantine hydrochloride | |
CN106748725B (en) | A kind of preparation method of 4-chloro-2-fluoro-phenylpropionic acid | |
CN103694166A (en) | Preparation method of 3-[(3-amine-4-methylamino-benzoyl)(pyridin-2-yl)amine]ethyl propionate | |
CN110452139B (en) | Preparation method of 2-methyl-3-bromo-6-methylsulfonyl benzonitrile | |
CN111848426B (en) | Industrial production method of aceclofenac | |
CN104628573A (en) | Method for synthesizing hexanitrostilbene from hexanitrobibenzil | |
CN101844964A (en) | Method for preparing octachloronaphthalene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191231 |